Baylor College of Medicine: Leukemia, Myeloid, Acute trials

The registry lists 11 Leukemia, Myeloid, Acute studies with Baylor College of Medicine as lead sponsor. 3 are open to participants now and 4 have results posted.

Early Phase 1 2Phase 1 5Phase 2 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AMLRecruitingNCT07059975Early Phase 1
• Leukemia Adapted ProtocolRecruitingNCT06928909
• Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)RecruitingNCT06345027Phase 1
• Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 DepletionActive, not recruitingNCT05236764Not applicableResults posted
• Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)TerminatedNCT00579111Phase 1/2Results posted
• Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHDCompletedNCT00539695Phase 2Results posted
• T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell GraftsCompletedNCT00368355Phase 2Results posted
• Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 AntigenActive, not recruitingNCT04219163Phase 1
• Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)CompletedNCT03568994Early Phase 1
• Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)CompletedNCT02494167Phase 1
• Administration of Donor T Cells With the Caspase-9 Suicide GeneActive, not recruitingNCT01494103Phase 1